期刊文献+

肺腺癌人转录辅助因子4过表达与淋巴转移的相关性 被引量:2

Correlation between overexpression of PC4 in lung adenocarcinoma with lymph node metastasis
下载PDF
导出
摘要 目的探讨肺腺癌组织中人转录辅助因子4(PC4)过表达对淋巴转移的促进作用。方法选取96份肺腺癌组织标本,采用免疫组织化学法和荧光定量PCR法检测PC4蛋白和mRNA的表达水平,并分析其与淋巴转移和肿瘤分期的相关性。结果肺腺癌组织PC4蛋白和mRNA表达明显正相关(r=0.63,P<0.01);PC4蛋白表达与淋巴转移正相关(χ2=8.29,P<0.01),与TNM分期正相关(χ2=4.71,P<0.05);PC4 mRNA与淋巴转移正相关(χ2=8.40,P<0.01),与TNM分期正相关(χ2=5.10,P<0.05)。结论 PC4过表达与肺腺癌患者的淋巴转移、TNM分期密切相关,PC4可能促进肺腺癌的淋巴转移。 Objective To investigate the promotion effect of human transcriptional positive cofactor 4 (PC4) overexpression on lymphatic metastasis in lung adenocarcinoma .Methods 96 samples of lung adenocarcinoma tissue were collected .The immuno‐histochemistry(IHC) and real‐time quantitative polymerase chain reaction (qRT‐PCR) were adopted for detecting the expression levels of PC4 protein and mRNA .The correlation of PC4 expression with lymphatic metastasis and TNM stage was analyzed .Re‐sults The expression of PC4 protein was positively correlated mRNA in lung adenocarcinoma (r=0 .63 ,P〈0 .01);the expression of PC4 protein was positively correlated with lymph node metastasis (χ2 =8 .29 ,P〈0 .01) and TNM stage (χ2 =4 .71 ,P〈0 .05);the expression of PC4 mRNA was also positively correlated with lymph node metastasis (χ2 = 8 .40 ,P〈 0 .01) and TNM stage (χ2 =5 .10 ,P〈0 .05) .Conclusion PC4 overexpression is found to be closely associated with the lymph node metastasis and TNM stage .PC4 may facilitate the lymph node metastasis of lung adenocarcinoma .
出处 《重庆医学》 CAS 北大核心 2015年第11期1449-1451,1456,共4页 Chongqing medicine
基金 国家自然科学基金资助项目(81172239)
关键词 腺癌 转录辅助因子4 聚合酶链反应 免疫组织化学 淋巴转移 lung adenocarcinoma human transcriptional positive cofactor 4 polymerase chain reaction immunohistochemis-try lymphatic metastasis
  • 相关文献

参考文献15

  • 1Ceylan KC, Kaya SO, Samancilar O, et al. The effects of neoadjuvant chemotherapy on pulmonary structures: a quantitative analysis[J]. Thorac Cardiovasc Surg, 2012,60 (2) : 111-115.
  • 2Conesa C,Acker J. Subl/PC4 a chromatin associated pro tein with multiple functions in transcription [J]. RNA bi ology,2010,7(3) :287 290.
  • 3Shi C, Zhu Y, Zhau HE, et al. PC4, a novel marker for stem cell transformation and cancer progression[J]. J Bio- technol, 2008,136 Suppl : $189-193.
  • 4Peng Y,Yang JZhang E,et al. Human positive coactiva- tor 4 is a potential novel therapeutic target in non-small cell lung cancer [J]. Cancer Gene Ther, 2012,19(10): 690-696.
  • 5Travis WD, Brambilla E, Muller-Hermelin HK, et al. World Health Organization classification of tumours : pathology and genetics of tumours of the lung, pleura, thymus and heart [M]. Lyon: IARC Press, 2004 : 35-44.
  • 6Sobin LH ,Gospodarowicz MK,Wittekind C. TNM classi- fication of malignant tumours[M]. 7th ed. New York:Wi- ley-Liss Inc,2009 : 138 146.
  • 7Deng B,Sun Z,Jason W,et al. Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center pa tients[J]. Ann Surg Oncol, 2013,20 Suppl 3 : $701-708.
  • 8Vilmar A, Garcia Foncillas J, Huarriz M, et al. RT-PCR versus immunohistochemistry for correlation and quantifi- cation of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC [J]. Lung Cancer,2012,75(3) :306-312.
  • 9Booton R,Ward T,Ashcroft L,et al. ERCC1 mRNA expres- sion is not associated with response and survival after piati num-based chemotherapy regimens in advanced non small cell lung cancer[J]. J Thorac Oncol, 2007,2 (10) : 902-906.
  • 10Kozlowski M, Naumnik W, Niklinski J, et al. Lymphatic yes sel invasion detected by the endothelial lymphatic marker D2 40 (podoplanin) is predictive of regional lymph node status and an independent prognostic factor in patientswith resected esophageal cancer[J]. Folia Histochem Cy tobiol,2011,49(1) :90-97.

二级参考文献21

  • 1汤钊猷.转移复发-肝癌研究的重中之重[J].中华消化外科杂志,2007,6(1):2-2. 被引量:12
  • 2Jemal A, Bray F, Center MM, et al. Global cancer statis tics[J]. CA Cancer J Clin,2011,61(2) :69-90.
  • 3Perz JF, Armstrong GL, Farrington LA, et al. The contri butions of hepatitis B virus and hepatitis C virus infec tions to cirrhosis and primary liver cancer worldwide[J]. J Hepatol, 2006,45 ( 4 ):529-538.
  • 4Monney L, Sabatos CA, Gaglia JL, et al. Thl-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease[J]. Nature, 2002, 415(6871) :536-541.
  • 5Nakae S,Iikura M,Suto H,et al. TIM 1 and TIM-3 en- hancement of Th2 cytokine production by mast cells[J]. Blood,2007,110(7) :2565-2568.
  • 6Nakae S, Iikura M,Suto H,et al. TIM-1 and TIM-3 en- hancement of Th2 cytokine production by mast cells[J]. Blood,2007,110(7) :2565-2568.
  • 7Wiener Z, Kohalmi B,Pocza P, et al. TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimu- lated mast cells[J]. J Invest Dermatol, 2007,127 ( 4 ) : 906- 914.
  • 8Zhuang X, Zhang X, Xia X, et al. Ectopic expression of TIM-3 in lung cancers:a potential independent prognostic factor for patients with NSCLC[J]. Am J Clin Pathol, 2012,137(6) :978 -985.
  • 9Li H, Wu K, Tao K, et al. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma [J]. Hepatology, 2012, 56 ( 4 ) : 1342 -1351.
  • 10Yuan J,Jiang B, Zhao H,et al. Prognostic implication of TIM-3 in clear cell renal cell carcinoma[J]. Neoplasma, 2014,61(1) :35-40.

共引文献6

同被引文献37

  • 1Ge H, Roeder RG. Purification, cloning, and characteri- zation of a human coactivator, PC4, that mediates tran- scriptional activation of class II genes[J]. Cell, 1994, 78(3): 513-523.
  • 2Kumari S, Das C, Sikder S, et al. Identification and char- acterization of nonhistone chrornatin proteins: human pos- itive coactivator 4 as a candidate[J]. Methods Mol Biol, 2015,1288: 245-272.
  • 3Akimoto Y, Yarnamoto S, Iida S, et al. Transcription co- factor PC4 plays essential roles in collaboration with the smallsubunit of general tramcription factor TFIIE[J]. Genes cells, 2014, 19(12): 879-890.
  • 4Calvo O, Manley JL. The transcriptional coactivator PC4/ Sub1 has multiple functions in RNA polymerase II tran- scription[J]. The EMBO Journal, 2005, 24(5): 1009-1020.
  • 5Garcia A, CoUin A, Calvo O. Sub1 associates with Spt5 and influences R.NA polymerase II transcription elongation rate[J]. Mol Biol Cell, 2012, 23(9), 4297-4312.
  • 6Sikorski TW, Ficarro SB, Holik J, et al. Sub1 and RPA associate with RNA polymerase II at different stages of transcription[J]. Mol Cell, 2011, 44(3): 397-409.
  • 7Tavenet A, Suleau A, Dubreuil G, et al. Genorne-wide location analysis reveals a role for Sub1 in RNA poly- merase III transcription[J]. Proc Nail Acad Sci uSA, 2009,106(34):14265-14270.
  • 8Wang Z,Roeder RG . DNA topoisomerase I and PC4 can interact with human TFIIIC to promote both accurate termination and transcription reinitiation by RNApoly- merase Ⅲ [J]. Mol Cell, 1998,1(5):749-757.
  • 9Mortusewicz O, Evers B, HeUeday T. PC4 promotes genome stability and DNA repair through binding of ssD- NA at DNA damage sites[J]. Oncogene, 2016, 35(6):761- 770.
  • 10Wang JY, Sarker AH, Cooper PK, et al. The single- strand DNA binding activity of human PC4 prevents mu- tagenesis and killing by oxidative DNA damage [J]. Mol cell biol, 2004, 24:6084 - 6093.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部